Navigation Links
New operation for kidney cancer

According to researchers, that three years on, a group of kidney cancer patients have had no recurrence of their disease, thanks to a new procedure. Researchers at the University of Mississippi have developed a new operation for kidney cancer, called interventional-MRI renal cryosurgery. //The procedure relies on magnetic resonance imaging to guide a surgical probe while removing cancerous tissue. So high-tech is this procedure, that the surgeon could demonstrate his 60 operation to a group of colleagues in Italy using telemedicine.

The team now reports on progress among the first 60 patients, since April 1998 when the first operation was performed. In all, 80 tumours have been treated and there has been no recurrence at the treated sites. Better still, kidney function has been preserved in all the patients (while conventional surgery can lead to loss of function). It's an excellent result, for many of these patients would formerly have faced the spread of the primary tumour. A few of the patients, however, needed more than one treatment - further development of the procedure should, hopefully, make it a 'one off' procedure which can be offered more widely.


'"/>




Page: 1

Related medicine news :

1. MSI puts on hold plans for operations in Chennai
2. New operation for swallowing problems
3. Memory deprivation after operations
4. Making operation and recovery time shorter
5. Lessening operation and recovery time
6. UK Plastic surgeons cash in as cosmetic operations soar
7. Regional Cooperation Promoted in Southeast Asia
8. UP government decides to suspend doctor named in sting operation
9. Regional cooperation on health care services
10. Health ministers meet in Dhaka on regional cooperation
11. ‘Search and Destroy’ operation against dengue mosquitoes in Philippins
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New operation for kidney cancer

(Date:11/26/2014)... November 26, 2014 The Deptford ... have launched a partnership designed to improve the ... congestive heart failure (CHF) patients in the South ... and Lourdes Cardiology team will help CHF patients ... protocols. This partnership pairs the Cardiac Recovery program ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Increasing ... stringent drug safety regulations are expected to be ... period. Growing prevalence of acute and chronic ailments ... for new drug development. Moreover, growing adverse drug ... the same has become the need of the ...
(Date:11/26/2014)... 26, 2014 German scientists say carbon-based ... can cause mesothelioma that looks and acts similar to ... article on the research. Click here to read ... for Toxicology and Experimental Medicine in Hannover injected 500 ... of the rats eventually developed mesothelioma , how ...
(Date:11/26/2014)... 26, 2014 The city of San ... is moving forward with a plan to recycle wastewater ... host Sharon Kleyne supports the San Diego plan as ... (TWM). According to Kleyne, by recycling water that San ... water could be greatly reduced. (Spagat, E, “San Diego ...
(Date:11/26/2014)... Loffler Companies has been selected as a 2014 ... information and news publication for resellers of imaging technology, ... Loffler has earned this prestigious award and the seventh ... honor the best and the brightest in the imaging ... chosen for their innovative marketing and sales programs, community ...
Breaking Medicine News(10 mins):Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2
... and more so when its risk looms large. Women who ... risk of developing cervical cancer in the 20 years following ... is one of the major causes of death from cancer ... for cervical cancer, incidence rates and deaths drop significantly. ...
... in the United States, who had voiced vociferous protests ... are now having no such qualms about the introduction ... Merck & Co. and GlaxoSmithKline are still in the ... but concerns had been voiced about them promoting promiscuity ...
... to develop abnormal behaviour, says a study.,Psychologist Seth Pollak ... Wisconsin-Madison studied// 18 four-year-old adoptees, who had spent their ... in a neglected environment. ,Even though the children ... in some cases - they might still display some ...
... and Diabetic Centre at Vasavi Mahal in Chitradurga, ... Dr Narayana Murthy and Dr. Muralidhar conducted the ... ,Dr. Muralidhar is the Principal of Basaveswara Medical ... and treatment to control diabetes is very important ...
... study, published in the November issue of the Journal ... in residential care can reduce their incidence of falls ... years.// ,To determine whether vitamin D supplementation can ... people in residential care who are not classically vitamin ...
... strong risk factor for sudden cardiac death, with the ... ,The authors writing in the October issue of the ... mellitus in industrialized countries is rapidly increasing, and diabetes ... sudden cardiac death. ,The authors examined the ...
Cached Medicine News:Health News:Religious groups overcome objections to cervical cancer vaccines 2
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Aridis ... to produce novel therapies for infectious diseases, announced ... M.D., an internationally recognized key opinion leader in ... Company,s scientific advisory board. Founder and ... stated, "We believe Dr. Opal,s extensive experience investigating ...
(Date:11/26/2014)... CHARLOTTE, N.C. , Nov. 25, 2014  At ... San Antonio this October, KaVo Kerr Group ... Institute Technology Expo, offering attendees the opportunity to see ... to well-respected key opinion leaders deliver lectures on the ... Kerr Group products include the new DEXIS CariVu Caries ...
Breaking Medicine Technology:Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... well-tolerated with signs of durable,disease control in advanced ... /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented preliminary results ... trial (DC-MEL-202). The,results showed that UVIDEM was well ... response in patients with,progressive metastatic melanoma. , The ...
... trial presented at ENDO 2007 , ,- Regulatory approvals ... recruitment in Europe , ,MONTREAL, QUEBEC -- (MARKET WIRE) ... that 26-week data from,its first Phase 3 study testing ... ENDO, the 89th,annual meeting of the Endocrine Society. The ...
Cached Medicine Technology:IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: